Biosensors International Group has announced that a drug-eluting stent developed by the company has demonstrated equal safety and efficacy as compared to Johnson & Johnson’s drug-eluting stent, Cypher Select, based upon nine-month clinical and angiographic follow-up data.
No Pingbacks for this post yet...
The healthcare industry is an ever-changing, ever-adapting environment. MET can help you ensure you are kept up to date by providing you with the latest industry news.
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| << < | > >> | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 | ||||